AI-supported pathology workflows
Digital pathology workflows and AI-supported tools, including Ibex Galen™ Prostate, support prostate biopsy assessment, specialist review and more consistent prostate cancer reporting.
UROLOGY DIAGNOSTIC EXPERTISE
Urology diagnostics to support patient care
Urology care often requires different diagnostic perspectives — from laboratory testing and imaging to pathology, genetics and molecular diagnostics.
Unilabs supports urologists with connected diagnostic services that help guide investigation, treatment decisions, monitoring and follow-up across common and specialised urological questions.
Diagnostic services and expertise for urology
Unilabs combines routine testing, specialist interpretation and advanced diagnostics to support urologists across common and complex clinical questions. Our services bring together laboratory medicine, pathology, genetics and radiology to help guide diagnosis, treatment planning, monitoring and follow-up.
Urine analysis, microbiology, culture, resistance testing and selected infection diagnostics to support the investigation of urinary tract symptoms, recurrent infections and abnormal urine findings.
Laboratory testing to support the assessment of renal function, haematuria, inflammation, metabolic findings, stone-related questions and other urinary abnormalities.
PSA-related testing, biopsy pathology, molecular diagnostics and specialist interpretation to support prostate evaluation, risk assessment, diagnosis, treatment planning and follow-up.
Specialised prostate MRI, expert radiology interpretation and UroImage support to assist with prostate cancer detection, staging, biopsy planning and multidisciplinary decision-making.
Cytology, pathology, laboratory testing and selected molecular diagnostics to support the investigation of haematuria, bladder abnormalities and bladder cancer pathways.
Specialist pathology and cytology expertise for urological tissue and cell samples, supporting tumour classification, clinically relevant reporting and therapy-relevant decisions.
Genetic and molecular diagnostics for selected uro-oncology questions, including hereditary risk assessment, tumour profiling and ctDNA-based monitoring where clinically appropriate.
Hormonal, reproductive and selected laboratory diagnostics to support fertility-related questions, endocrine assessment and andrological investigations.
TECHNOLOGY IN UROLOGY
Advanced diagnostic technologies supporting urology care
Digital pathology, prostate MRI, AI-supported workflows and molecular technologies help support complex diagnostic questions in urology — from prostate cancer assessment to uro-oncology monitoring and follow-up.
Digital pathology and specialist review
Digital slide workflows enable pathology teams to collaborate across locations, support second opinions and bring specialist input into complex urological cases.
Prostate MRI and UroImage technology
Specialised prostate MRI, structured imaging protocols and UroImage workflows support prostate cancer detection, staging, biopsy planning and radiology-pathology collaboration.
Molecular and genomic technologies
NGS, tumour profiling and ctDNA-based approaches support hereditary risk assessment, therapy-relevant questions and molecular monitoring in selected uro-oncology pathways.
BLADDERCARE™ UROLOGICAL CANCER DIAGNOSTICS
BladderCare™ for bladder cancer follow-up
BladderCare™ is a urine-based genomic test that can support the monitoring of non-muscle invasive bladder cancer.
It provides molecular information that may help physicians assess recurrence risk and support follow-up decisions alongside cystoscopy, cytology and clinical evaluation.
HEREDITARY UROLOGICAL CANCER RISK
NGS panels for hereditary cancer risk
NGS-based hereditary cancer panels can support the investigation of inherited risk in selected urological cancer pathways.
They may help inform risk assessment, family counselling, surveillance discussions and preventive strategies where clinically appropriate.
TUMOUR PROFILING
NGS tumour profiling for uro-oncology
NGS tumour profiling can identify clinically relevant genomic alterations in tumour tissue to support therapy-relevant discussions in selected urological cancers.
The results may help inform treatment selection, further molecular work-up or multidisciplinary case discussions, depending on tumour type and clinical context.
SIGNATERA™ MRD MONITORING
Signatera™ for molecular residual disease monitoring
Signatera™ is a personalised, tumour-informed ctDNA test designed to support molecular residual disease monitoring in selected solid tumours.
By tracking tumour-specific DNA signals in the blood over time, it can provide additional molecular information for recurrence risk assessment, treatment-response monitoring and follow-up discussions where clinically appropriate.
Swipe to find out more
DIAGNOSTIC SUPPORT FOR UROLOGISTS
Why choose Unilabs for urology diagnostics?
Unilabs supports urologists with access to specialist expertise across laboratory medicine, radiology, pathology, genetics and molecular diagnostics.
Specialists by your side: Medical and scientific experts can support test selection, diagnostic pathways and result interpretation when needed.
Multidisciplinary urology expertise: Radiology, pathology, genetics, laboratory medicine and molecular diagnostics can be connected for broader clinical insight.
Advanced solutions for selected cases: Prostate MRI, specialist pathology, NGS, BladderCare and ctDNA-based monitoring can support selected uro-oncology pathways.
Find your expert
Find the right specialist for your needs.
Need diagnostic support? Our team is here to help you find the right services, tests or expertise for your practice.